Innovation & Quality


NUMECA will be attending BioWin Day 2018 - the 7th edition of this international conference gathering all stakeholders active in the biotechnology and medical technology sector. Come visit us at booth #27.

 


Ensuring reliable manufacturing, complying with strategic timelines, controlling production process costs and fulfilling regulatory requirements are critical challenges in the medical field.

Simulation or virtual prototyping can vastly help the healthcare industry to respond to those challenges and at the same time cut down on the go-to-market time, keeping costs low for the patient.

As a flow simulation and optimization software provider, NUMECA offers an extended suite of software covering a broad range of (bio-)medical applications. Examples can range from optimizing aerosol deposition in the nasal cavity to mixing and cleaning optimization in vessels to modeling blood clots in arteries etc.

 


About BioWin Day 2018

The central theme of this edition is "Artificial Intelligence for Health : Between Dream and Reality".

BioWin Day is the international networking event that BioWin - the Health Cluster of Wallonia (Belgium) – organizes once every 2 years. The event gathers all stakeholders active in the biotechnology and medical technology sectors.

BioWin Day is an opportunity for industrial and academic players (companies, research centres, organizations and universities) to share their knowledge and expertise concerning scientific and/or business-oriented issues but also to meet potential partners. This year, more than 500 visitors are expected!

Check out the full agenda of the event here.

 


Date: December 4th 2018

Venue: Aula Magna, Ottignies-Louvain-la-Neuve, Belgium

https://biowinday2018.b2match.io/

 

Share this article

Author

Anne-Marie Schelkens

Anne-Marie is the Marketing & Communications Coordinator at Numeca International, based in Brussels. Prior to joining the company in 2016, she held various roles in the automotive and ICT industry in Belgium and Spain.

Comments

Leave first comment here...

LEAVE A COMMENT